Results overview: Found 3 records in 0.02 seconds.
Articles, 2 records found
Research literature, 1 records found
Articles 2 records found  
1.
8 p, 501.2 KB Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Español de Linfomas/ Trasplante de Médula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation / Sureda, Anna (Institut d'Investigació Biomèdica Sant Pau) ; Canals, Carme (European Society for Blood and Marrow Transplantation (Barcelona)) ; Arranz, Reyes (Hospital de la Princesa (Madrid)) ; Caballero, Dolores (Hospital Clínico Universitario (Salamanca)) ; Ribera, Josep Maria (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Brune, Mats (Sahlgrenska University Hospital. Hematology Section) ; Passweg, Jacob (Hopitaux Universitaires de Geneve. Departement Medecine Interne) ; Martino, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ; Valcárcel, David (Institut d'Investigació Biomèdica Sant Pau) ; Besalduch, Joan (Hospital Son Dureta (Palma de Mallorca)) ; Duarte, Rafael (Institut Català d'Oncologia) ; León, Angel (Hospital de Jerez de la Frontera) ; Pascual, Maria Jesús (Hospital Carlos Haya (Málaga)) ; García-Noblejas, Ana (Hospital de la Princesa (Madrid)) ; López Corral, Lucia (Hospital Clínico Universitario (Salamanca)) ; Xicoy, Bianca (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Sierra Gil, Jordi (Institut d'Investigació Biomèdica Sant Pau) ; Schmitz, Norbert (Asklepios Klinik St. Georg. Hematology/Oncology Department)
Background: Although Hodgkin's lymphoma is a highly curable disease with modern chemotherapy protocols, some patients are primary refractory or relapse after first-line chemotherapy or even after high-dose therapy and autologous stem cell transplantation. [...]
2012 - 10.3324/haematol.2011.045757
Haematologica, Vol. 97, Núm. 2 (january 2012) , p. 310-317  
2.
15 p, 1.7 MB The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature / Díaz Beyá, Marina (Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)) ; Brunet Mauri, Maria Salut (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Nomdedéu Guinot, Josep Francesc (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Pratcorona, Marta (Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)) ; Cordeiro, Anna (Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)) ; Gallardo, David (Institut Català d'Oncologia) ; Escoda, Lourdes (Hospital Joan XXIII (Tarragona)) ; Tormo, Mar (Hospital Clínico y Universitario de Valencia) ; Heras, Inmaculada (Hospital General Universitario Morales Meseguer (Múrcia)) ; Ribera Santasusana, J. M. (José María) (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Duarte, Rafael (Institut Català d'Oncologia) ; Llano Queipo, María Paz de (Hospital Universitario Virgen de la Victoria (Màlaga, Andalusia)) ; Bargay, Joan (Hospital Son Llàtzer (Palma de Mallorca, Mallorca)) ; Sampol, Antonia (Hospital Son Espases (Palma de Mallorca, Mallorca)) ; Nomdedeu, Meritxell (Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)) ; Risueño, Ruth M. (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Hoyos, Montserrat (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Sierra Gil, Jorge (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Monzo, Mariano (Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)) ; Navarro, Alfons (Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)) ; Esteve, Jordi (Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)) ; Cooperative AML group CETLAM ; Universitat Autònoma de Barcelona
Long non-coding RNAs (lncRNAs) are deregulated in several tumors, although their role in acute myeloid leukemia (AML) is mostly unknown. We have examined the expression of the lncRNA HOX antisense intergenic RNA myeloid 1 (HOTAIRM1) in 241 AML patients. [...]
2015 - 10.18632/oncotarget.5148
Oncotarget, Vol. 6 Núm. 31 (October 2015)  

Research literature 1 records found  
1.
94 p, 5.2 MB Avances en la profilaxis antifúngica primaria en la fase precoz del trasplante alogénico / Sánchez-Ortega, Isabel ; Duarte Palomino, Rafael F., dir. ; Sierra Gil, Jordi, dir. ; Universitat Autònoma de Barcelona. Departament de Medicina
En el trasplante alogénico (alo-TPH), las infecciones fúngicas invasivas (IFI) siguen teniendo un gran impacto sobre la morbi-mortalidad. La profilaxis primaria, es la única estrategia farmacológica de manejo de las infecciones fúngicas que ha demostrado disminuir la mortalidad global y la mortalidad relacionada con la IFI en el alo-TPH y en base a una revisión sistemática y metaanálisis de 64 estudios randomizados [Robenshtok E et al. [...]
Invasive fungal infections (IFI) are recognized as the leading infectious cause of mortality in allogeneic blood and marrow transplant (allo-BMT) recipients. As a general antifungal strategy, primary prophylaxis reduces all-cause mortality and IFI-related mortality in allo-BMT, and should be used for all allo-BMT recipients according to a systematic review and meta-analysis of 64 randomized controlled trials [Robenshtok E et al. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2014  

See also: similar author names
1 Duarte, Ricardo
2 Duarte, Rosa
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.